Walter Douthat

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics

David C. Wheeler, Bergur V. Stefánsson, Oleksandr Bilchenko et al. · Nephrology Dialysis Transplantation · 2020 · 180 citations · Full text

Increasing access to integrated ESKD care as part of universal health coverage

David C.H. Harris, Simon Davies, Fredric O. Finkelstein et al. · Kidney International · 2019 · 168 citations · Full text

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Zien Zhou, Meg Jardine, Qiang Li et al. · Stroke · 2021 · 111 citations · Full text

Burden of disease: prevalence and incidence of ESRD in Latin America

Marta Gonzalez-Bedat, Guillermo Rosa-Díez, Roberto Pecoits‐Filho et al. · Clinical Nephrology · 2015 · 65 citations

A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D—a randomised multicentre international clinical trial

Jorge B. Cannata‐Andía, Augusto Díaz-Sottolano, Pehuén Fernández et al. · BMC Medicine · 2022 · 65 citations · Full text